The Third Edition of Knowles Neoplastic Hematopathology has been thoroughly updated by the world's experts to cover all aspects of neoplastic hematopathology, a field that covers disorders of the bone marrow, spleen, and lymphatic system. Now in full-color, this completely revised and expanded edition integrates the basic science, modern diagnostic techniques, and clinical aspects of malignant diseases affecting these organs. It is the most comprehensive, encyclopedic textbook concerning neoplastic hematopathology available on the market today.

Preceded by (work): Neoplastic hematopathology / edited by Daniel M. Knowles. 2nd ed. c2001.

This updated reference has been prepared by the world's leaders in neoplastic hematopathology, a field that covers disorders of the bone marrow, spleen, and lymphatic system. This is the only comprehensive, encyclopedic text that covers the three major organ systems and integrates basic science, modern diagnostic techniques, and clinical aspects of malignant diseases affecting these organs. The Second Edition features several new contributors, more full-color illustrations, updated chapters, and three new chapters--Clinical Relevance of the Revised European/American Lymphoma Classification of Non-Hodgkin's Lymphomas; Normal Histology and Immunoarchitecture of the Lymphohematopoietic System; and Application of Molecular Genetics to the Diagnosis and Classification of Acute Leukemias. Compatibility: BlackBerry(R) OS 4.1 or Higher / iPhone/iPod Touch 2.0 or Higher /Palm OS 3.5 or higher / Palm Pre Classic / Symbian S60, 3rd edition (Nokia) / Windows Mobile(TM) Pocket PC (all versions) / Windows Mobile Smartphone / Windows 98SE/2000/ME/XP/Vista/Tablet PC

This volume, edited for the last time by H.E. Spiegel, continues the objective of expanding the intellectual horizon of clinical chemistry. The fields of analytical, anatomical, sub-cellular and molecular sciences are all represented in this volume.* Detailed reviews by practicing scientists* Covers a broad range of clinical chemistry on a theoretical and practical basis* Includes easy to read chapters combining science and perspectives in a changing scientific landscape

Continuing in the rich tradition of this popular handbook series, The Washington Manual® of Hematopathology provides concise, high-yield content that reflects today’s fast-changing advances in the field. Edited by Drs. Brooj Abro, John L. Frater, Louis P. Dehner, John D. Pfeifer, and Anjum Hassan, this all-new volume focuses on the essential information you need to know, using a concise format, along with numerous figures, tables, algorithms, and images throughout. In one convenient, portable resource, you’ll find complete coverage of hematopathology—both benign and malignant entities—all at your fingertips for quick review and reference.

This revised and updated second edition of Handbook of Hematologic Malignancies continues to be an essential and "go-to" resource for the busy hematologist, hematologic oncologist, hematopathologist, oncology advanced practice provider, oncology nurse, and trainee. Concisely organized, each chapter provides the most current, need-to-know points of diagnosis, prognosis, therapeutic management, and clinical trial opportunities for each hematological malignancy. Chapters are complete with richly illustrated figures to highlight the hematopathologic characteristics of diseases in addition to helpful tables on differential diagnosis, prognostic scoring systems, molecular profiles, and therapeutic options. A new case-based chapter concludes the handbook with clinical cases designed to test a clinician's knowledge of pathologic diagnosis and clinical presentation of diseases covered in the book. With over twenty new FDA-approved indications since publication of the first edition, including breakthroughs with CAR-T therapy, and other evidence-based treatment options for patients with hematologic disease, this book serves as quick reference to practice changing information on challenging diagnostic dilemmas, frontline and refractory treatment scenarios, and more. The subspecialty field of hematologic oncology is ever-changing and expanding with available treatment options and this second edition keeps the busy clinician abreast of recent findings and their impact on evidence-based treatment and management. Written by experienced clinicians at the world-renowned Moffitt Cancer Center in Tampa, Florida, as well as contributions from leading academicians, hematologists, and oncologists throughout the country, this unique handbook is packed with authoritative knowledge and clinical insight into all known hematologic cancers. Key Features: Includes seven new chapters covering CAR-T and novel therapeutic options including CD19 CAR-T therapy, novel cellular therapies, cytokine release syndrome, cancer associated thrombosis, and more Comprises compact and updated disease-site chapters describing new standards of care and management considerations in bullet point format with key references Highlights important diagnostic tools that assist with conducting key differential diagnoses and unveiling answers to diagnostic dilemmas Provides updates of potential practice-changing clinical trials and paradigm shifting treatment considerations in each disease-based chapter